3/6
10:07 am
bbot
BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor
Low
Report
BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor
3/6
08:03 am
bbot
BridgeBio Oncology Therapeutics (BBOT) had its price target raised by HC Wainwright from $27.00 to $29.00. They now have a "buy" rating on the stock.
Low
Report
BridgeBio Oncology Therapeutics (BBOT) had its price target raised by HC Wainwright from $27.00 to $29.00. They now have a "buy" rating on the stock.
3/5
04:05 pm
bbot
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
Medium
Report
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2/12
04:05 pm
bbot
BBOT to Participate in Upcoming Investor Healthcare Conferences
Low
Report
BBOT to Participate in Upcoming Investor Healthcare Conferences
2/11
04:05 pm
bbot
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2/10
06:05 pm
bbot
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) was given a new $23.00 price target on by analysts at Stifel Nicolaus.
Medium
Report
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) was given a new $23.00 price target on by analysts at Stifel Nicolaus.
1/27
02:07 pm
bbot
Biotech investor Cormorant secures $150M for another SPAC deal [Yahoo! Finance]
Low
Report
Biotech investor Cormorant secures $150M for another SPAC deal [Yahoo! Finance]
1/23
08:44 am
bbot
Helix Acquisition prices $150M initial public offering [Seeking Alpha]
High
Report
Helix Acquisition prices $150M initial public offering [Seeking Alpha]
3/5/2026
04:05 pm
BBOT
bridgebio oncology therapeutics, inc.
BEAT
Report
5.4%
bridgebio oncology therapeutics, inc.
3/5/2026
04:05 pm
BBOT
bridgebio oncology therapeutics, inc.
BEAT
Report
5.4%
bridgebio oncology therapeutics, inc.
Raymond James Financial, Inc.
1/27
08:01 am
bbot
Form 8-K Helix Acquisition Corp. For: Jan 22
Medium
Report
Form 8-K Helix Acquisition Corp. For: Jan 22
1/26
05:03 pm
bbot
Form 4 Helix Acquisition Corp. For: Jan 26 Filed by: Chen Bihua
Medium
Report
Form 4 Helix Acquisition Corp. For: Jan 26 Filed by: Chen Bihua
1/23
04:32 pm
bbot
Form 424B4 Helix Acquisition Corp.
Low
Report
Form 424B4 Helix Acquisition Corp.
1/23
06:04 am
bbot
Form EFFECT Helix Acquisition Corp.
High
Report
Form EFFECT Helix Acquisition Corp.
1/22
08:34 pm
bbot
Form 3 Helix Acquisition Corp. For: Jan 22 Filed by: Schmid John P.
High
Report
Form 3 Helix Acquisition Corp. For: Jan 22 Filed by: Schmid John P.
1/22
08:33 pm
bbot
Form 3 Helix Acquisition Corp. For: Jan 22 Filed by: Obradovic Nebojsa
High
Report
Form 3 Helix Acquisition Corp. For: Jan 22 Filed by: Obradovic Nebojsa
1/22
08:33 pm
bbot
Form 3 Helix Acquisition Corp. For: Jan 22 Filed by: Tripp Caleb
High
Report
Form 3 Helix Acquisition Corp. For: Jan 22 Filed by: Tripp Caleb
1/22
08:33 pm
bbot
Form 3 Helix Acquisition Corp. For: Jan 22 Filed by: McKenna Mark C.
High
Report
Form 3 Helix Acquisition Corp. For: Jan 22 Filed by: McKenna Mark C.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register